Lopez Gonzalez Santana BTREX PLUS Dietary Supplement Recall: Damaged Tablets
Lopez Gonzalez Santana recalls BTREX PLUS dietary supplement with damaged tablets. Consumers should check UPC 05380930801 and lot #30636 for affected units.
Lower-risk recall
CGMP Deviations: Presence of damaged tablets
Contact the company
What happened, in plain English
Lopez Gonzalez Santana is recalling BTREX PLUS dietary supplement caplets due to damaged tablets. This could affect product safety and quality. Read more at govinfonow.com/recall/14476-lopez-gonzalez-santana-btrex-plus-dietary-supplement-recall-damaged-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/14476-lopez-gonzalez-santana-btrex-plus-dietary-supplement-recall-damaged-tablets · Updated October 4, 2026 · FDA enforcement record: FDA #F-0665-2021
Cite this page
“Lopez Gonzalez Santana BTREX PLUS Dietary Supplement Recall: Damaged Tablets.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/14476-lopez-gonzalez-santana-btrex-plus-dietary-supplement-recall-damaged-tablets. Based on FDA recall #F-0665-2021 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0665-2021%22&limit=1).
Why it’s dangerous
Damaged tablets in dietary supplements can lead to potential safety issues. The presence of damaged tablets may affect the product's quality and safety.
Who’s affected
People who purchased BTREX PLUS dietary supplement caplets with UPC 05380930801 and lot #30636 are affected. Those who have taken the product may be at risk of consuming damaged tablets.
How to tell if you have this one
Check for UPC 05380930801 on the product label. The affected lot number is #30636 with an expiration date of 01/2022.
- Brand
Lopez Gonzalez Santana- Product
BTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801- Category
Food
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Domestic distribution only-PR
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| F-0665-2021 | BTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801; Lot #30636, Expiration Date 01/2022 | 894 bottles |
| F-0666-2021 | BTREX PLUS, Dietary Supplement 2 caplets bottles, UPC 05380930802 (Physician Samples); Lot #30637, Expiration Date 01. 2022 | 4641 units (2 tablet bottles) |
What to do — step by step
Check Product Label
Look for UPC 05380930801 and lot number #30636 on the dietary supplement caplets.
Where it went and when
Where it was distributed
Distributed in Puerto Rico.
FDA distribution: “Domestic distribution only-PR” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Puerto Rico.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall is due to damaged tablets, but the product may still be safe to use if the damage is minor.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-0665-2021 (May 25, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-0665-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.